Bio-Bridge Science Announces Receipt of Bus. License for Bio-Bridge JRS Biosciences (Beijing) Co., Ltd., a Cell Culture Mediu...
October 19 2009 - 11:09AM
Business Wire
Bio-Bridge Science, Inc. (OTCBB:BGES), a biotechnology company
engaged in the commercial development of vaccines and
vaccine-related products announced today that the Company received
a business license from the Beijing Administration for Industry and
Commerce of the People’s Republic of China (“PRC”) indicating
approval of the formation of Bio-Bridge JRS Biosciences (Beijing)
Co., Ltd. (“Bio-Bridge JRS”). Bio-Bridge JRS, is located in
Beijing, China, and is expected to commercially produce cell
culture medium and related biomaterials for use in scientific
research and vaccine production. Bio-Bridge JRS will complement
Bio-Bridge Science’s previous acquisition of Xinheng Baide
Biotechnology Co., Ltd., a serum manufacturing company, by
strengthening the Company’s position as a vaccine-related
biomaterials supplier in the PRC.
“We are pleased to receive the business license indicating
approval of the formation of Bio-Bridge JRS by the Beijing City
government of the PRC,” said Dr. Liang Qiao, Chairman and CEO of
Bio-Bridge Science. “We expect Bio-Bridge JRS to provide Bio-Bridge
Science with an additional source of revenue, diversified product
offerings, as well as, cell culture medium and bio-materials for
use in our internal vaccine development.”
This press release contains forward-looking statements.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and
service demand and acceptance, changes in technology, economic
conditions, the impact of competition and pricing, government
regulation, and other risks defined in this document and in
statements filed from time to time with the Securities and Exchange
Commission. All such forward-looking statements, whether written or
oral, and whether made by or on behalf of the company, are
expressly qualified by these cautionary statements and any other
cautionary statements which may accompany the forward-looking
statements. In addition, the company disclaims any obligation to
update any forward-looking statements to reflect events or
circumstances after the date hereof. Please refer to the Company's
SEC filings for additional information
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bio Bridge Science Inc (CE) (OTCMarkets): 0 recent articles
More Bio-Bridge Science, Inc. News Articles